Pharming Group (OTCMKTS:PHGUF) Shares Gap Down – Here’s What Happened

Shares of Pharming Group NV (OTCMKTS:PHGUF) gapped down prior to trading on Thursday . The stock had previously closed at $1.28, but opened at $1.18. Pharming Group shares last traded at $1.18, with a volume of 10,000 shares trading hands.

Pharming Group Price Performance

The firm has a market capitalization of $791.86 million, a PE ratio of 59.03 and a beta of 0.45. The firm’s 50 day moving average price is $1.48 and its two-hundred day moving average price is $1.62. The company has a quick ratio of 2.03, a current ratio of 2.63 and a debt-to-equity ratio of 0.40.

Pharming Group (OTCMKTS:PHGUF) last announced its earnings results on Thursday, May 7th. The biotechnology company reported ($0.01) earnings per share for the quarter. The firm had revenue of $72.45 million during the quarter, compared to analysts’ expectations of $92.06 million. Pharming Group had a net margin of 3.30% and a return on equity of 4.64%.

About Pharming Group

Pharming Group NV is a Netherlands-based biopharmaceutical company specializing in the development and commercialization of protein replacement therapies for rare diseases. Founded in 1988 and headquartered in Leiden, the company leverages transgenic technology to produce recombinant proteins, with its flagship product RUCONEST (recombinant C1 esterase inhibitor) indicated for the treatment of acute hereditary angioedema (HAE) attacks. RUCONEST is approved and marketed in the United States, Europe and several other territories through partnerships with leading specialty pharmaceutical companies.

Beyond RUCONEST, Pharming maintains a diversified pipeline targeting unmet needs in rare and ultra-rare disorders.